{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:16:29Z","timestamp":1782537389218,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014472","name":"Scientific Research Foundation of Hunan Provincial Education Department","doi-asserted-by":"publisher","award":["22A0348"],"award-info":[{"award-number":["22A0348"]}],"id":[{"id":"10.13039\/100014472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ7176"],"award-info":[{"award-number":["2024JJ7176"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmcl.2026.130654","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:30:37Z","timestamp":1775896237000},"page":"130654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents"],"prefix":"10.1016","volume":"137","author":[{"given":"Zhiqiang","family":"long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5230","key":"10.1016\/j.bmcl.2026.130654_bb0005","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.7667636","article-title":"CDC25 phosphatases as potential human oncogenes","volume":"269","author":"Galaktionov","year":"1995","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130654_bb0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: key players? Good targets?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6591","key":"10.1016\/j.bmcl.2026.130654_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/382511a0","article-title":"Cdc25 cell-cycle phosphatase as a target of c-myc","volume":"382","author":"Galaktionov","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2026.130654_bb0020","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1016\/j.bmcl.2012.05.019","article-title":"Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation","volume":"22","author":"Ravinder","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130654_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127849","article-title":"Pyridones in drug discovery: recent advances","volume":"38","author":"Zhang","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130654_bb0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0223-5234(00)00149-5","article-title":"Synthesis and antitumour activity of 4-hydroxy-2-pyridone derivatives","volume":"35","author":"Cocco","year":"2000","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejmech.2013.04.043","article-title":"Microwave-assisted synthesis of some new pyrazolopyridines and their antioxidant, antitumor and antimicrobial activities","volume":"66","author":"El-Borai","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejmech.2015.10.008","article-title":"Structure activity relationships of 4-hydroxy-2-pyridones: a novel class of antituberculosis agents","volume":"106","author":"Ng","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2014.07.052","article-title":"Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety","volume":"84","author":"Nasr","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.bmcl.2026.130654_bb0050","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/S0040-4020(01)00193-4","article-title":"Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"57","author":"Parreira","year":"2001","journal-title":"Tetrahedron"},{"issue":"18","key":"10.1016\/j.bmcl.2026.130654_bb0055","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1021\/jm050392q","article-title":"Discovery of a 1 H-Benzoimidazol-2-yl-1 h-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor i receptor kinase with in vivo antitumor activity","volume":"48","author":"Wittman","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0060","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acs.jmedchem.5b01716","volume":"59","author":"Boezio","year":"2016","journal-title":"J Med Chem"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130654_bb0065","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1021\/jm800832q","volume":"51","author":"Velaparthi","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127113","article-title":"Novel vanillin derivatives containing a 1,3,4-thiadiazole moiety as potential antibacterial agents","volume":"30","author":"Wu","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2026.130654_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2009.05.016","article-title":"The structure of n-allyl-(5-phenyl-[1,3,4]thiadiazol-2-yl) amine in solution and the solid state studied by the 1H, 13C, 15N NMR spectroscopy and x-ray crystallography","volume":"970","author":"Strzemecka","year":"2010","journal-title":"J Mol Struct"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130654_bb0080","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.tetlet.2015.02.027","article-title":"N.I. Svintsitskaya, reactions of 5-substituted 1,3,4-thiadiazole-2-thiones with chloroacetylenephosphonates","volume":"56","author":"Egorov","year":"2015","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2026.130654_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129438","article-title":"Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity","volume":"93","author":"Okada","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130654_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103657","article-title":"Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: the contribution of the substituents at 5th positions is size dependent","volume":"97","author":"Omar","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115585","article-title":"Design, synthesis, activity and molecular dynamics studies of 1,3,4-thiadiazole derivatives as selective allosteric inhibitors of SHP2 for the treatment of cancer","volume":"258","author":"Liu","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130654_bb0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/jm001027w","article-title":"Synthesis of 2-Amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity","volume":"44","author":"Clerici","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113322","article-title":"2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole, moiety as potent a-glucosidase and e. coli b-glucuronidase inhibitors","volume":"216","author":"Li","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0110","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/acs.jmedchem.9b01035","article-title":"Development and characterization of a fluorescent probe for GLS1 and the application for high-throughput screening of allosteric inhibitors","volume":"62","author":"Xu","year":"2019","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130654_bb0115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bmc.2016.03.009","article-title":"Cerione, design and evaluation of novel glutaminase inhibitors","volume":"24","author":"McDermott","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130654_bb0120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2026.130654_bb0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.6023\/cjoc201405020","article-title":"Synthesis and biological activities of novel 2,5-Disubstituted-1,3,4-thiadiazole derivatives","volume":"35","author":"Li","year":"2015","journal-title":"Chin J Org Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2014.05.001","article-title":"Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents","volume":"81","author":"Xie","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejmech.2017.12.038","article-title":"Design, synthesis and biological evaluations of novel pyridonethiazole hybrid molecules as antitumor agents","volume":"145","author":"Xie","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130654_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3184\/174751912X13272462962072","article-title":"A facile and efficient iodination of 5,6-di(arylamino)pyridine-2,3-diones","volume":"36","author":"Xie","year":"2012","journal-title":"J Chem Res"},{"key":"10.1016\/j.bmcl.2026.130654_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128447","article-title":"Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors","volume":"54","author":"Zhao","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130654_bb0150","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11164-012-0495-z","article-title":"Synthesis of 4,5,6-trisubstituted 2,3-pyridinedionesvia mannich reaction and oxidation\u2013Michael additionof 3-hydroxy-2(1H)-pyridinones","volume":"38","author":"Xie","year":"2012","journal-title":"Res Chem Intermed"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130654_bb0155","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/jm0708331","article-title":"Antimitotic and antiproliferative activities of chalcones: forward structure\u2013activity relationship","volume":"51","author":"Boumendjel","year":"2008","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:17Z","timestamp":1778570537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S0960894X26001216"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130654","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130654"}}